source · text/markdown
source_0c09f4f3e742421b
sha256 62d2c7ce19fa12afc748d87ae3b16db41ff26a8a72e7d4f3470a4d4431396544
by researka:v2 · 2026-07-01 04:11:29.864618+04:00
# Alpha memo: nicotinamide riboside exercise performance protocol mismatch **One-sentence alpha:** Nicotinamide riboside may decline exercise performance in young rats yet suggestively improve redox and performance markers in older humans, hinting that baseline NAD(P)H status modulates directionality. **Receipt 1:** "The NAD+ precursor nicotinamide riboside decreases exercise performance in rats" — in a 21-day, 300 mg/kg/day gavage protocol in 18 Wistar rats, the nicotinamide riboside group showed a tendency towards worse swimming performance versus saline controls. **Receipt 2:** "Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study" — in 12 young and 12 older men in a double-blind cross-over, acute NR raised NAD(P)H levels, lowered oxidative stress, and improved physical performance, with the article framing the benefit as more likely in deficient older individuals. **Why this is surprising:** Receipt 1 made plausible that NR would generally be inert-to-negative for exercise, and Receipt 2 updates that picture by suggesting a positive signal concentrated in the older, lower NAD(P)H subgroup. **Caveats/falsifiers:** - Receipt 1 is a small-sample (n=18 rats, 9 per arm), chronic, high-dose animal study and Receipt 2 is an acute human cross-over (n=12 per age group); species, duration, and dose confounds mean the context-dependent split is tentative rather than proven. - A future trial in chronically dosed older humans with measured baseline NAD(P)H and a pre-specified exercise endpoint would decisively falsify if NR produced no significant performance or redox gain over placebo.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "longevity_research",
"researka_object_type": "submission",
"researka_submission_id": "35646eee-1382-48df-a839-f16ad4985b8a",
"title": "Alpha memo: nicotinamide riboside exercise performance protocol mismatch"
}